Transient neuroprotection by SRY upregulation in dopamine cells following injury in males.
Daniel P Czech, Joohyung Lee, Jeanne Correia, Hannah Loke, Eva K Möller, Vincent R Harley
Index: Endocrinology 155(7) , 2602-12, (2014)
Full Text: HTML
Abstract
Emerging evidence suggest sex-specific regulation of dopamine neurons may underlie susceptibility of males to disorders such as Parkinson's disease (PD). In healthy male dopamine neurons, the Y-chromosome gene product, the sex-determining region on the Y chromosome (SRY) modulates dopamine biosynthesis and motor function. We investigated the regulation and function of SRY in a model of dopamine cell injury. Treatment with the dopaminergic toxin, 6-hydroxydopamine (6-OHDA), significantly elevated SRY mRNA expression (9-fold) in human male dopamine M17 cells. SRY up-regulation occurred via the p-quinone pathway, associated with a 3.5-fold increase in expression of GADD45γ, a DNA damage inducible factor gene and known SRY regulator. In turn, a signaling cascade involving GADD45γ/p38-MAPK/GATA activated the SRY promoter. Knockdown of SRY mRNA in 6-OHDA-treated M17 cells was deleterious, increasing levels of reactive oxygen species (ROS), pro-apoptotic marker PUMA mRNA, and cell injury (+25%, +32% and +34%, respectively). Conversely, ectopic over-expression of SRY in 6-OHDA-treated female SH-SY5Y cells was protective, decreasing ROS, PUMA, and cell injury (-40%, -46%, and -30%, respectively). However, the 6-OHDA-induced increase in SRY expression was diminished with higher concentrations of toxins or with chronic exposure to 6-OHDA. We conclude that SRY upregulation after dopamine cell injury is initially a protective response in males, but diminishes with gradual loss in dopamine cells. We speculate that dysregulation of SRY may contribute the susceptibility of males to PD.
Related Compounds
Related Articles:
2015-04-01
[Acta Pharmacol. Sin. 36(4) , 517-27, (2015)]
2015-01-01
[Stem Cells Dev. 23(20) , 2435-42, (2014)]
2014-12-15
[J. Immunol. 193(12) , 6135-43, (2014)]
2011-09-23
[J. Biol. Chem. 286(38) , 33335-44, (2011)]
Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
2006-08-01
[Eur. J. Clin. Invest. 36(8) , 588-96, (2006)]